Arsenal Participates in the 2018 Spring US-China Venture Summit



Winter Park, FL – May 8, 2018 – Arsenal was pleased to participate in the 2018 Spring US-China Venture Summit held in Boston by the Boston Chinese Investment Club (BCIC), MIT China Development Student Initiative (CDSI), DME-Health and NECINA on May 5th, 2018. Arsenal General Partners, Jason Rottenberg and Orlando Mendoza participated on the VC Panel along with Chong Xu, Senior Associate with F-Prime Capital. The panel shared their knowledge of growth in international investments, what VC’s look for in investment opportunities and hedging investment risks.

“The Arsenal Team was honored to participate with such a strong group of leading industry knowledge experts,” commented Orlando Mendoza. “We welcome the opportunity to share our expertise and expand growth here in the US and abroad.”

The well attended event was co-sponsored by multiple science and technology innovation parks in China to attract overseas start-up projects. The Summit focused on recent hotspots in technological innovation areas, including artificial intelligence, biomedicine, fintech, blockchain, and new materials.



Arsenal is a unique growth equity firm that focuses at the intersection of government, large corporations, and emerging technology companies. Since 2000, Arsenal has partnered with visionary entrepreneurs building exceptional businesses in the enterprise, commerce/logistics, and healthcare sectors. Arsenal adds value by fostering relationships from our unique network and experience working with the Federal government and Global 1000 Companies. Leveraging our deep network within government agencies solidifies our position and is often our invitation into competitive syndicates. With a nationwide team, we take a theme driven approach that drives methodical outreach and targeted investments. Read more about Arsenal Venture Partners at www.arsenalvp.com and connect with us on LinkedIn and Twitter.


Media Contact:

Tricia Bradley
Marketing Director
Arsenal Venture Partners

Comments are closed.